China medical device regulations
Official sources linkedNMPA rules and guidance for medical device market access, registration, and lifecycle compliance. Each code opens a metadata page with the official source and readable HTML when available.
| Code | Regulation | Category | Effective | Provenance |
|---|---|---|---|---|
| Laws and Regulations | NMPA Laws and Regulations Collection Comprehensive collection of NMPA laws and regulations including the revised Good Manufacturing Practice for Medical Devices (effective November 2026). | General | 2024 | Official |
| SAMR Decree No. 47 | Provisions for Medical Device Registration and Filing SAMR Decree No. 47 as published in NMPA English. Authority English is a translation; the Chinese expression controls. Articles 1–124 are ingested from the official HTML page. Covers Class I filing, Class II/III registration, and technical documentation requirements. | Registration | October 1, 2021 | Official |
| State Council Order No. 739 | Regulations on Supervision and Administration of Medical Devices Current consolidated Chinese expression of the Regulations on Supervision and Administration of Medical Devices, downloaded from the Ministry of Justice National Administrative Regulations Database. It incorporates the December 6, 2024 amendments effective January 20, 2025 — still the newest MOJ edition (re-downloaded 29 August 2026, byte-identical, all content assertions passing). Articles 1–107 and Chapters I–VIII are ingested; Chinese is the controlling text. | General | June 1, 2021 | Official |
| NMPA Official Portal | National Medical Products Administration - Medical Devices Official NMPA portal for medical device news, announcements, and regulatory updates. Covers policy measures to advance drug and medical device regulation reform. | General | 2018 | Official |
| Classification Rules | Rules for Classification of Medical Devices Rules for Classification of Medical Devices (CFDA Order No. 15, published July 14, 2015, effective January 1, 2016). Controlling Chinese expression ingested from the Ministry of Justice departmental-rules database: Articles 1–10 plus the complete Annex classification-determination table (医疗器械分类判定表) reproduced cell-for-cell as text — all 21 usage-form rows across the four groups (passive/active × contact/non-contact), the Roman-numeral class cells, and the legend notes. The NMPA English page (english.nmpa.gov.cn/2019-10/11/c_415411.htm) is retained as the authority translation; its Annex table is image-only, which is why the corpus text is the Chinese original. Repeals the 2000 Classification Rules (former SDA Order No. 15). | Classification | January 1, 2016 | Official |
Changes after registration in China
Source-linked rules for common changes to a registered medical device. Read the scope and conditions with each rule; unverified details are listed separately.
Does changing a device brand name or logo require an update?
A change to the registered brand name and a change to logo artwork can follow different rules. The legal manufacturer, device design and intended purpose remain the same.
A source-verified answer for this specific scenario is not yet published.
How do I update a manufacturer's name without changing the legal entity?
The same legal manufacturer changes its name, potentially alongside the device brand. A transfer to another legal entity is a separate question; permission to combine filings needs its own evidence.
A source-verified answer for this specific scenario is not yet published.
What changes when the manufacturer's office address changes?
An office address change for the same legal entity, potentially alongside name and brand changes. This does not cover moving a factory or manufacturing site, and a combined filing cannot be assumed.
A source-verified answer for this specific scenario is not yet published.
Does a catalogue or reference code change affect registration or UDI?
Check which identifier actually changes. A commercial catalogue, REF or order code is not automatically a device model, registered identifier, GTIN or UDI-DI. Rules for one identifier do not establish the route for another.
A source-verified answer for this specific scenario is not yet published.
Can a registration transfer to a different legal entity?
A real change of legal manufacturer, registration holder or owner. This differs from renaming the same entity; a change of local representative or importer alone does not establish a registration transfer route. Where other changes occur with the transfer, the exact combination and sequence need separate evidence.
A source-verified answer for this specific scenario is not yet published.
Can several changes be filed together?
Changes to brand, manufacturer name, office address and reference codes may occur together, including with a real transfer to another legal manufacturer, registration holder or owner. Assess transfer with each single change, and transfer with brand plus reference, manufacturer name plus reference, or office address plus reference changes: seven transfer combinations in total. Evidence must establish the exact combination and the order of filings and approvals. These combinations and their sequence are not all verified by the rules below; a rule for one change does not prove that a single application, fee or review period covers the combination.
A source-verified answer for this specific scenario is not yet published.
What these codes are
Each row above represents one regulatory instrument. Its code is the authority’s identifier. A regulation page collects the metadata and official source; when readable HTML is available, article links can open and highlight the exact cited passage.
Continue from regulations into practical research
Keep China as the target market while you move into registration records, classification, cross-country product research, or pathway planning.
Classify a device for China
Check a preliminary NMPA risk class.
Search registered products
Inspect public NMPA records.
Compare products across markets
Search the same product in multiple country registries.
Build a registration plan
Estimate pathway, government fees, preparation, and review time.
Build a reusable product master
Structure company, product, model, approval, and evidence facts once.
Map dossier reuse and deltas
Compare existing evidence against China needs.
Build a market-launch workpaper
Connect route, evidence, labels, representatives, and launch dependencies.
Assess a regulatory change
Test a current NMPA update against one product and its evidence.